type 1 and type 2 diabetes mellitus
Endocrinology · 2005–2007
2decisions
2medicines
0carried consumer input
0individual submissions
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| Insulin Glulisine treatment of Type 1 and Type 2 diabetes mellitus | Mar 2007 | Recommended | no section in document |
| insulin glargine Treatment of type 1 and type 2 diabetes mellitus in adults and children aged 6-15 years who require insulin for control of hyperglycaemia. | Jul 2005 | Not recommended | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.